Advertisement

Psychopharmacologia

, Volume 2, Issue 2, pp 93–106 | Cite as

Autonomic and psychic effects of yohimbine hydrochloride

  • Gunnar Holmberg
  • Samuel Gershon
Original Investigations

Summary

Yohimbine in a dose of 0.5 mg/kg has been given to 51 male mental hospital subjects and nine normal volunteers.

It has produced both cholinergic and adrenergic-type autonomic effects and psychic effects simulating an anxiety state. The degree of both these responses to yohimbine correlates highly with the basic level of emotional reactivity.

Central nervous system depressants, amobarbital and Ro 5–0690, reduced the degree of response to yohimbine, whilst the CNS stimulants imipramine and epinephrine potentiated the yohimbine effect. Yohimbine in the dosage here employed did not have any blocking effect against injected epinephrine.

Activation of the psychotic picture was produced by yohimbine in some schizophrenic cases.

Yohimbine is a promising compound for use as an autonomic test drug.

Keywords

Hydrochloride Epinephrine Imipramine Emotional Reactivity Anxiety State 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ackner, B., andG. Pampiglione: An evaluation of the sedation threshold test. J. psychosom. Res.3, 271–281 (1959).Google Scholar
  2. Barry, D. T.: Some features of the pharmacological actions of yohimbine and ergotamine. Arch. int. Pharmacodyn.55, 385–401 (1937).Google Scholar
  3. Bovet, D., etF. Bovet-Nitti: Médicaments du système nerveux végétatif. Basel and New York: Karger 1948.Google Scholar
  4. Bradley, P. T., andP. M. Jeavons: The effect of chlorpromazine on sedation and convulsive thresholds in schizophrenic patients. Electroenceph. clin. Neurophysiol.9, 661–682 (1957).Google Scholar
  5. Braun, M., andS. Rettek: A study of the value of the Funkenstein test as an indicator of the effectiveness of ataractic drugs. Amer. J. Psychiat.116, 66–67 (1959).Google Scholar
  6. Brill, N. Q., E. Crumpton, S. Eiduson, H. M. Grayson andL. I. Hellman: Predictive and concomitant variables related to improvement with actual and simulated ECT. A.M.A. Arch. gen. Psychiat.1, 263–272 (1959).Google Scholar
  7. Douglas, D. B., andP. H. Hoch: Blood pressure studies in schizophrenia: Atropine and saline. Psychiat. Quart.30, 204–210 (1956).Google Scholar
  8. Funkenstein, D. H., M. Greenblatt andH. G. Solomon: A test which predicts the clinical effects of electric shock treatment on schizophrenic patients. Amer. J. Psychiat.106, 889–901 (1950).Google Scholar
  9. — — —: An automatic nervous system test of prognostic significance in relation to electroshock treatment. Psychosom. Med.14, 347–362 (1952).Google Scholar
  10. Goodman, L. S., andA. Gilman: The pharmacological basis of therapeutics. New York: Macmillan & Co. 1958.Google Scholar
  11. Grosz, H. J., andI. Miller: Two factors limiting the reliability of the Mecholyl test: Variability in day-to-day responses and dissimilarity between simultaneous determinations. J. nerv. ment. Dis.127, 417–429 (1958).Google Scholar
  12. Hoffer, A.: Effect of atropine on blood pressure of patients with mental and emotional disease. A.M.A. Arch. Neurol. Psychiat.71, 80–86 (1954).Google Scholar
  13. —, andM. J. Callbeck: Prognostic value of the Mecholyl test. Dis. nerv. Syst.20, 209–210 (1959a).Google Scholar
  14. — —: Differential response of schizophrenic and other psychiatric patients to atropine. Dis nerv. Syst.20, 387–390 (1969b).Google Scholar
  15. Holmberg, G., and S.Gershon: Yohimbine as an autonomic test drug. Nature (in press).Google Scholar
  16. Ivy, A. C., andL. R. Krasno: Amphetamine (Benzedrine) sulphate. A review of its pharmacology. War Med. (Chicago)1, 15–42 (1941).Google Scholar
  17. Jang, C. S.: The potentiation and paralysis of adrenergic effects by ergotoxine and other substances. J. Pharmacol. exp. Ther.71, 87–94 (1941).Google Scholar
  18. Kendall, M. G.: Rank correlation methods. London: Griffin 1948.Google Scholar
  19. Lindemann, E., andJ. E. Finesinger: The effect of adrenaline and mecholyl in states of anxiety in psychoneurotic patients. Amer. J. Psychiat.95, 353–370 (1938).Google Scholar
  20. Lunde, F., E. Mansfield andJ. A. Smith: Mecholyl chloride as a prognostic test in psychiatric patients. J. nerv. ment. Dis.127, 430–436 (1958).Google Scholar
  21. Maas, J. W.: Reliability of the metacholine (Mecholyl) test. A.M.A. Arch. Neurol. Psychiat.79, 585–589 (1958).Google Scholar
  22. Myerson, A., J. Loman, andW. Dameshek: Physiologic effects of acetyl-betamethylcholine (Mecholyl) and its relationship to other drugs affecting the autonomic nervous system. Amer. J. med. sci.193, 198–214 (1937).Google Scholar
  23. Nelson, R., andE. Gellhorn: The influence of age and functional neuropsychiatric disorders on sympathetic and parasympathetic functions. J. psychosom. Res.3, 12–26 (1958).Google Scholar
  24. Nickerson, M.: The pharmacology of adrenergic blockade. Pharmacol. Rev.1, 27–101 (1949).Google Scholar
  25. Ozturk, O. M., A. O. Battle andG. H. Aivazian: On the epinephrine-Mecholyl test. Dis. nerv. Syst.20, 250–253 (1959).Google Scholar
  26. Raymond-Hamet, C. R.: Sur un nouveau cas d'inversion des effets adrénaliques. C.R. Acad. Sci. (Paris)180, 2074 (1925).Google Scholar
  27. Satterfield, H. J.: Prediction of improvement by use of epinephrine-metacholine (Mecholyl) test. A.M.A. Arch. Neurol. Psychiat.81, 513–516 (1959).Google Scholar
  28. Schneider, J. A., andE. B. Sigg: Neuropharmacological studies on ibogaine, an indole alkaloid with central-stimulant properties. Ann. N.Y. Acad. Sci.66, 765–776 (1957)Google Scholar
  29. Shagass, C.: The sedation threshold. A method for estimating tension in psychiaric patients. Electroenceph. clin. Neurophysiol.6, 221–233 (1954).Google Scholar
  30. —, andJ. Naiman: The sedation threshold as an objective index of manifest anxiety in psychoneurosis. J. psychosom. Res.1, 49–57 (1956).Google Scholar
  31. Sloane, R. B., D. J. Kewus andP. Slater: Prognostic value of adrenaline and mecholyl responses in electroconvulsive therapy. J. psychosom. Res.2, 271 to 273 (1958).Google Scholar
  32. Thorpe, J. G., andJ. C. Barker: Objectivity of the sedation threshold. A.M.A. Arch. Neurol. Psychiat.78, 194–196 (1957).Google Scholar
  33. Yonkman, F. F., D. Stilwell andR. Jeremias: The adrenolytic and sympatholytic actions of yohimbine and ethyl yohimbine. J. pharmacol. exp. Ther.81, 111–115 (1944)Google Scholar

Copyright information

© Springer-Verlag 1961

Authors and Affiliations

  • Gunnar Holmberg
    • 1
    • 2
  • Samuel Gershon
    • 1
    • 3
  1. 1.Joint Research Project in Schizophrenia and PsychopharmacologyUniversity of Michigan and Ypsilanti State HospitalYpsilanti
  2. 2.Danderyd 1Schweden
  3. 3.Department of PharmacologyUniversity of MelbourneCarlton, N. 3.Australia

Personalised recommendations